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Previous molecular studies investigating the pres-
ence of HTL V -I proviral DNA in cell lines and tissue 
samples of patients with cutaneous T -cell lymphoma 
(CTCL) have reported a detection rate ranging from 
0-92%. Despite the lack of epidemiologic data link-
ing HTLV-I infection with CTCL, the molecular data 
still invite speculation regarding the precise role of 
HTL V -I in the pathogenesis of CTCL. To determine 
the detection rate of HTLV-I proviral DNA among 
CTCL patients referred to our medical center, we 
analyzed Epstein-Barr virus-transformed cell lines 
established from peripheral blood of seven CTCL 
patients and 43 tissue samples from 22 patients with 
different stages of disease. Genomic DNA was poly-
merase chain reaction-amplified with primers within 
the HTLV-I tax gene region. Amplification products 
C utaneous T -cell lymphoma (CTCL), a malignancy of mature T lymphocytes (T cells), appears fir st in the skin and slowly progresses through stages o f increasing cutaneous and extracutaneous involve-. m ent (Greer et ai, 1993) . CTCL has two clinical 
variants: (i) mycosis fun goides , whjch classically evolves slowly 
through pro gressive stages of cutaneous in volvem ent (patch , 
plaque , tumor and / or erythroderma) with progression to ex tra cu-
taneous involvem ent (lymph nodes and viscera) and (ii) Sezar y 
syndrome, a leukemic variant, which presen ts with genera li zed 
exfoljative erythrode rma , lymphadenopathy, and leukocytosis with 
atypie<t1 circulating lymphocytes witb hyperconvoluted nu clear 
contours (Sezary cells) (Lutzner ct ai , '1971) . 
T he etio logy of CTC L is unkno wn, but a retroviral e tio logy has 
been an attractive hypo thesis (MacKie, 1981) since the discovery o f 
the first human retroviru s, HTLV -1, and its asso ciation w ith adult 
T -cell leukemia/lymphoma (ATL) (Poiesz el ai, 1980). T he most 
intriguing support for an asso ciation o f HTLV-l and CT C L has 
been from a series of re po rts demonstrating evidence of retroviral 
DNA in cell lines and ti ssues o f pati ents with C T C L (Manzari et ai , 
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were probed with nested oligonucleotide probes b y 
Southern blot analysis. No HTLV-I proviral se-
quences were detected in the samples (0/50). Using 
HTLV -1111 pol primers, no HTL V -I pol gene sequences 
were detected . In tissues from one patient, HTLV-U 
pol and tax gene sequences were detected; however, 
HTL V -II proviral integration was not detected b y 
Southern blot analysis of the genomic DNA. Our data 
suggest: (i) HTLV-I does not appear to be a primary 
etiologic agent in CTCL; and (ii) HTL V - II pol and tax 
gene sequences can be detected in a minority o f 
CTCL patients, but this does not necessarily imply an 
etiologic role. Key words: mycosis JmtgoideslSezary syn-
dl'OmelPCR amplificatioll. ] ],west Dermatol 107:308-313, 
1996 
1987; Ana gnostopo ul os et (/1, 1990; De tmar ct ai, 1991; H all et ai, 
1991.; Zucker-Franklin ct ai, 1991; D ' lncan et ai, 1992; Srivasta va et 
ai , 1992; Zu 'ker-Frankl in et (/1 , 1992; Bazarbachi c l ai, 1993 ; C h an 
et ai , 1993 ; Whittaker and Luzzatto , 1993 ; G ho sh et ai, 1994; Manca 
et ai, 1994; Pancake et ai, 1995). 
Man zari et al (1 987) reported the m oIeculm' detection o f re tro-
viral DNA in a singl e cell line es tabl ished from the peripheral blood 
o f a patient with Sezary syndrom e and concluded that they had 
isolated a new re trovirus (designated HTLV-V) , whjch was closely 
related to H T LV-1. and associated with CT C L. Unfortunately, there 
has been no addi tional confirmato ry data since the time of the initial 
report to corroborate the exi ste nce of H T L V -V . Hall et al (1 991) 
reported the detection of a de fe ctive or truncated BTL V -! prov irus 
in an Epste in-B arr virus (EBV)-transformed B-cell lin e developed 
f!"Om peripheral bloo d mononuclear cell s £i'om a Sezary syndrome 
patient, pro vidin g cvid ence th at defec tive forms of HTLV-! m ay 
play a role in the development of CTCL. Zucker-Franklin et al 
generated cell lines from periphera l blood mononuclear cells from 
patients with early stages of mycosis fungoides and detected HTLV-I 
D NA sequcnces in up to fi ve o f nine cell I.ines by polymerase chain 
reaction (PCR) amplification (Zucker-Fnmklin el ai, 1991 , 1992). 
Subsequently, HTLV-I / Il proviral sequences have been detected by 
PCR amplification in variable percentages in the CT CL tissues , "vith 
repo rts r'mging frOI11 0% (C apesius el ai, 1991; Lisby el ai, 1992: 
Bazarbachi et ai, 1993; Boni et ai, 1996) up to 92% (Pancake et ai. 
1995). 
Based on these preliminary observations , w e sought to confirm 
and e xtend these findings by dete rmining whether H T LV-J could 
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be d e tected in EBV- transfo rmcd cell lin cs and cu ta neous Ics io ns at 
d iffe re nt disease stages as w c ll as in a w ide ran ge of cx tracu tan cou s 
si tes in patients with CTCL. 
M ATERJ ALS AN D M ETH ODS 
Patients T issue samples we re o btained Il'om 22 pa tien ts after informed 
con sen t was o b tain ed . Seventeen pati e llts h ad clinical. histopath o logic, and 
im munohisto logic findin gs diagnostic of C T CL (Ede lson , 1980 ; Murphy. 
i 988; Vowels el ai , 1994). O ne patie nt had CT C L and concurrent 
Hod gkin 's di sease; the H odgkin 's disc"se di at;nostic lymph node biopsy is 
inclu ded in o ur anal ysis. Fo ur patien ts had clinical, h.istopa tho logic, and 
inlJTI Ull o h isto )ogic fi ndings dia gn osti c of parapsori as is, a Hpl-cclIfsor state" of 
CTCL (Ede lson , 1980) . T w o of these fO llr patients weIl t on to develop 
unequivocal CTCL. T he cl inica l stage (Bunn and Lamberg, 1979) of each 
patient is li sted in Table I. 
Cell Lines EB V-transfo rmed cell lines we re es tablished ITom the pe riph-
eral blood of seven patien ts wi th e rythrodermic CTCL (Seza ry syndrome) 
and three health y adul t controls as prev io usly described (Hudson and H ays. 
1989). BrieAy. peri pheral blood mo no nuclear ce lls were prepared from 
hepa riJl.izcd who le blood by iso lation o n a fi co lJ t;radi ent . Approx im" tely 
5- 10 X 106 peripheral blood m ononuclear ce ll s were resuspended in 200 I.d 
of h ea t- inacti va ted te tal bovine Serul11 (FBS) to which we re added 2 III I of 
cell- free supernatant co ll cc ted from E 95- 8 ce ll s alld 10 nt; po l)'brc nc per 1111. 
T he cells we re incuba ted fo r 2- 4 h at 37°C in 5% CO2 , Fo llowing two 
wash es w ith phosphate buflc red sa line, the ce ll s were n:suspended at a 
concen tration o f 1.5 X 106 ce ll s pcr 1111 in RJ>M I 1640 medium supple-
men ted with 20% FBS and 0.5 Jig cyclosporill pe r 1111 , and 2-ml " Ii quots 
were plated in " 24-wcJI culture pla te. Each week, I ml of superna ta nt w as 
removed and replaced with frcsh medium witho ut cyclosporin . After 3- 4 
wk, visible clumps of ce ll s were apparent, and the culture was transferred to 
a 25- cm " Aask fo r expansio n . T he ce ll s were l1I ain t<l incd at a density of 10(' 
per =1 in RPMI 1640 and '10%, FBS. All ce ll cul ture reagents were o btained 
from Gm CO BRL (Gaithersburg , MD). Mycoplasma tcstin t; of culture 
supernatant by sta.lldard indirect DN A Auorescence assay tailed to demo n-
stra te ev idence o f rn ycoplaSl11:l contalninatio ll. J-li stochcllli c aI analysis ,vas 
performed a ll cytospin preparati o ll s wi th C DI 9 (B ce ll ) and CD2 (T ce ll) 
monoclonal :H1 tibodies (Becto n Dickinson, Sail J ose. CA) (Filln ,,, al. 1996). 
DNA Extraction Snap- troze n spccionens were processed by standard 
tecluuques of ce ll lysis, proteinase-K di t;estion . pheno l extractio n. and 
eth anol precipi tation (Lessin 1'1 ai, 199 1). Dedicated labora to ry space. 
equi p m en t, reage nts, an d suppli es \\'e re utili zed to con tro l fo r conta illina-
tion . AJJ D N A extracti on was performed in labo ratory space in w hich no 
known previo us rctrovi.ral CXpCrlHlc n tatio n occurred . 
Southern Blot Analysis R estri ctio n enz)'m e digestion . electrophoresis. 
b lotting and ul travio let cross-linking of n), lo lI tit ters (Zc tabind. C uno, Inc .. 
Meriden , CT), hybridizatio n. washin t; o f 6lte rs. auto radiot;raphy. and n.ick 
rransl ati on of radio labe led pro bes w ere perfo rll1 ed as previousl)' described 
(Lessin cf ai , 1988). Probes for immunoglobulin Jo eavy chain gene (G,"O-
w erley el nl, 1988), T-cell recepto r {3 locus (R usso ('I (/1, 1988), EBV (t;ifr 
from Dr. G. R overa), HT LV-I (Reddy ('/ nl, 1988), and HTLV-IJ (ATCC. 
Rockville, M D) were used. 
PCR Amplification A commerciall y avail able deoxyuracil triphospluote 
(dUTP) substi tution kit (G IBCO BRL) \Vas uti li zed in all PC R reactio ns to 
co n rrol for ca rry- over cOlltanlinatio n . Following 111:1I1Ufitctufc r 's rCC0I11-
mend ations, 0.5-1 .0 Jig o f t;enomic DNA was mixed in a tota l volume of 50 
fJ-l withi n standard buffer. 1..5 mM MgCI2 • 1.25 mM dco".-ym acil-dc-
oxynucleotide triphosphates mix , 100 nt; (15 pmo l) oD' and 5 ' primers (see 
below), 2.5 un.its o f Taq po lyme rase. and I unit of uracil D N A t; lyco),lase . 
R.eactio n I11L'l:tures we re incuba ted at 37°C fo r 10 min, then heated at 94°C 
for 8 min befo re 30 cycles of denatura tion at 94 °c for 30 s, annealing at 
55°C fo r 30 s. and ex te nsion at 72°C fo r 30 s. O ligonucleotide primers fo r 
conserved sequences o f the 1',,1 regions fo r I-IT L V - 1/ 11 (3' -SKll 0; 5' -
SK1ll) (Kwok ", (/1, 1988 ) (R ese:orch Genetics. Huntsvill e. AL) w ere used 
for HTLV-U II p{l i gene detectio n , whereas two sets of primers. pX -5' and 
pX- 3' (H all r l (/1, 199 1) o r SK43 and SK44 (J{wok CI al. 1988) (R esearch 
Genetics), we re used fo r ampli fica tion of H TLV-I or HTLV-1I11 lax gene 
sequen ces, respective ly. Anlpl ifica ti o ll products we re sized o n 2°ft, agarosc 
gels, b lo tted , and pro bed w ith 32P-IabcJed nes ted probes (Less in el ai, 199 1) 
for HTLV-I (PX- N ) (H all ci nl. 199 1) o r H T LV- IIII l ax (SK45) o r HT LV-I 
pol (SKI 12) and HT LV- II pol (S KI 8!) (Kwok el ai, 1983) (R esea rch 
Genetics) . Integri ty of all DN A samples was veri lled by PC R wi th primers 
detecting {3-actin gene (R esearch Genctics) and/ o r T -cell receptor-y t;enc 
rearrangem ent (E ourguin c ( ai, 1990) . D N A fTo m an HT LV-I-infectcd ce ll 
Ijne (MT-2) and an HT LV- II infected cell line (M oT ) servcd as positi ve 
controls (gifts fro m Drs. rt. Mettus and J. H oxie). PC R was performed in 
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T a ble I. Surn.rn.ary of Patie nt Sarn.ples : No D etection 
o f H T L V -I 
pCR I Southern Blot 
T isSll Cr 
Patien t D iagnosist' Stage" (s tatus'!) pX I" pol IC po l II ' 
I. PP 0 PC I-! (-) 
2. PI' 0 PC H (- ) 
3. PI' () PCH (- ) 
4. pp 0 PC H (- ) 
5. M F la PCI-I (+ ) 
6. M F la PC H (+ ) 
7. MF la PCH ( + ) 
8. M F Ia PCI-I (+ ) 
I). MF Ia PC H (+ ) 
pBL (- ) 
10. M F la PCH ( + ) 
PEL (- ) 
II. M F Ib PLQ (+ ) 
T MR (+ ) 
12. M F lIa LN ( - ) 
13. M F lib PLQ (+ ) 
T MR (+ ) 
1-1. M F li b T MR ( + ) 
15. M F li b I'LQ (+ ) 
T MR ( + ) 
16. SS III PBL- 1991 ( - ) 
PBL- 1992 (+ ) 
17. M F IV PLQ (+ ) 
PBL (+ ) 
LN (+ ) 
I S. MF IV T Mll (+ ) 
PEL (+) 
BM (- ) 
LN ( + LCT) 
19. SS IV PLQ ( + ) 
pBL (+ ) 
BM (+ ) 
LN (+ LCT) 
20. SS IV T MR (+ ) 
T MR (+ LCT) 
PBL (+ ) 
2 '1. SS/ H D IV LN (NS H D) 
22. SS IV ERY ( + ) + 
PLQ (+ ) + 
PB L-1 992 ( + ) + 
PEL-1993 ( + ) + 
BM (+ ) 
LN ( + LCT) + 
" PP. p;1 rap!ioriasis ; M F. m ycosis fungoidcs: S5, Sc zary syndrome; H D. Hodgkins' 
disc;\sc . 
/, N:ltio l1:11 Ca ncer Insti tu te COnsensus I'CPOft s[;)gi ng cri teria (Bunn .md L:lI11 hc r~. 
1979). 
' p H . skin pMch: PLQ. skin plaque; TMR. skin (mnor; Ell... Y, skin ery throdcfl11:l: 
PUL. periphera l blood lymp hocytes: LN. lym ph node ; BM. hone In:lrrow. Year of 
tiss\1 e acquisition is noted w hen m ore th ~l11 on e of the S;1mc tiss lie rypc was analyzed 
trom a g iven patient. 
,/ Sra tlls; morphologic and / or m olecul ar evidence of CTCL (+ ): no I.!v idcncc of 
CTCL ( - ). L T . hi sLO logic ev idence or large ce ll transfonll ari C)1t . NSI-ID. histologic 
ev idence of ll odular sclerosing Hodgkill 's disease. 
" - . 110 peR ;mtp li fi c:uioll produc ts idelllified. +. PC R am pli ficatio n prod uces 
ide llt.i fied . 
areas that wc re dedicated to such procedures and that we re fTec of plasmid 
an d p hage work . III addi t io n . we used reagents, w ate r, suppljes. and 
equi pment dcdi ca ted onl y to PC R . Amplill cation and nonam pli ficd samples 
were handled separately. All pC R amplj llcation w ith dUTP and SouthCrIl 
blot wo rk were perfo rmed in the Department of Derm ato lt;Y Laboratoo;es 
0 11 the secolld Aoor of the C linica l R.csea rch Building of the Un iversity of 
Pe lJnsylva ni a. Prio r to these cxpc rilll cn rs . n o work with retroviruses an d no 
PCR. ampli ficatio n of HTLV occurred in thi s tac ili ty. T he dUTP substitu-
tion ki t was used in the very fi rst pC R. perfo rmed w ith HTL V primers ill this 
fac ility ,l11d h as been used eve l' since. As a res ul t, \ \le have tightl y con tro ll ed 
fo r contamin atio n from PC R product ca rry-over. 
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Sequence Analysis Positive PCR results were confirm ed by seq uell cing. 
Samples were re-amplifled without using the dUTP substitution kit to 
f.1cilitate subclonillg and DNA sequenci ng. All of the PCR without dUTP, 
subclo ning. and sequencin g cxperilTlCnts were pcrforn1cd in a separate 
laboratory in the Molecular Biology ore Laborarorics a ll the third floor of 
the Medical Research Building of the Phil;ldelphia Veterans Aff.1irs Medical 
C C lltCL Fo ll o\ving the manu facturer's in struc tions, PC I"l... ;Hllplification 
products were ligated to TA vectors from an Invitrogen TA cloning kit 
(1IIvitTogen, S'\I1 Diego, CA) . DNA minipreparations were performed on 
cul tured colonies. and double-stranded plasmid DNA (3 f-l.g) was dCIl;Jtured 
with 1 M NaOl-l / l mM ethylenediamine tctraacetic acid . After neutraliza-
tion with 3 M ammonium acetate (pH 5.4), DNA was precipitated with 
1 OO 'Yo, cold ethanol, washed with 70')/" (vol/vol) eth'lIlol. dried, and anllealcd 
imlllediately with a sequencing primer (M 13 reverse or forward primers, 
Slratagcnc. La Jolla. CAl. DNA seq uencing was dOlle by the dideox),lIucle-
otidc chain tCTluinnrioJ) 111cthod (Sanger d ai, 1977) lIsing: a Scql1cnnsc kit 
(United States Biochcl1lical, Cleveland, O H). 
RESULTS 
No HTLV-I/II Sequences Detected in Cell Lines We first 
exa mined cell lin es establish ed from the peripheral b lood of seven 
patients with Seza ry syndrome and three hea lthy adu lt controls. 
Molecular and immunophenotypic analysis was performed on each 
cell lin e . Southern blot analysis of cell lin e genomic DNA revealed 
rearrangements in the immulJ o logic heavy chain locus with a 
gcnnline configuration in the T-cell receptor /3-gene locus and 
m onoclonal integration of E13V (data not shown). Immunohisto-
chemical analysis of cytospin preparations from the cell lin es 
revea led positive CD-19 (13 cell) sta ining whereas CD-2 (T cell) 
sta inin g was negative (data not shown). Thus, our cell Enes consist 
of monoclonal E13V -transformed B celis. These cell lines arc similar 
to those descr ibed in the initia l studies reporting the detection of 
HTLV-J or I-lTLV-J-Iike provirus sequen ces in CTCL (Manzari el 
nl, 1987; Hall cI nl. 199J; Z ucker-Franklin eI nl, 1991). Southern 
blot analysis utili zing a ful l length HTL V-I probe fai led to detect 
genomic integration of HTLV-1 proviral DNA in the ceU lines (data 
not shown) . PCR amplifi cation of genomic DNA with primers for 
the HTLV-I tnx regio n and 1'0/ region (identical to previous studies 
(Hall et (I I, 199 '1; Zucker- Frankli n et nl, 1991, '1992) fa iled to detect 
proviral sequellces in the cell lines tested (Fig 1). 
No HTLV-I Sequences Detected in Tissue Samples We 
next analyzed a variety of tissue sampl es (cutaneous and extracu-
taneous) from a wide range of disease stages. We so ught to 
determine whether the abil ity to de tect HTLV-I proviral sequ ences 
by PCR was related to diseilse progression or tissue site. Our 
ana lysis in clu ded 24 skin biopsies (four parapsoriasis, six patch, six 
plaque, seve n tumor, one e rythroderma), ten peripheral blood 
sa mples, six lymph node biopsies, and three bone marrow biopsies. 
T he results an: summal; zed in Table 1. All samples w e re first 
PCR-amplified for ,B-actin t.o ensure DNA integrity, as was done 
for the cell lines (Fig 1F). In skin sa mples in which the lymphocytic 
infiJtrate was sparse (i.e ., patch ; Sec Table 1), primers for T-cell 
receptor--y gene rearrangements were utilized to demonstrate the 
detection of T-ce ll in fi ltrates (Wood el nl, 1994) . In all samples 
tested, we were able to detect the T-cell infiltrate by PCR (data not 
shown). Except for positive controls, no sequen ces of the HTLV-1 
lax region were amplified or detected by Southern blot ana lys is 
from the samples. Positive control amplification signals fi'orn MT-2 
cell line were consistent throughout experimentation (Fig 1A,B). 
As with the analys is of the cell lin es above, 110 PCR amplifications 
were performed without the use of dUTPs and uracil DNA 
g lycoy lase digestion prior to amplifi cation. 
PCR ampli fication w ith primers for H TLV-lI ll pol sequences 
often resulted in vilriable intensity bands in tisslle samples as well as 
nonnal contro ls. When these products were probed with a nested 
probe specific for HTL V-I pol, they were uniformly negative 
(sim il ar to the cell tines in Fig 1e,D); hence, we did not detect 
HTLV -I pol sequences in the samples tested . 
HTLV- II Sequences Detected in One ' Patient When the 
products were probed with a nested probe specifIc for HTLV-II pol, 
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Figure 1. peR/Southern blot analysis faiJs to demonstrate HTLV-I 
In .>: and HTLV-IIIJ }Jo/ gene sequences in cell lines. MoT cell line 
(positive control for I-ITLV - II ). CTCL cdl lines ( /1I1I<'s 1-7). normal control 
ce ll lines (1lIlIes 8-10). and MT2 cel l line (positive control for HTLV-l) were 
analyzed. (A) HTLV-I 1((.>: PC R products (pX-S' and pX-3' primers). (B) 
PCR products ill (A) an: hybridized with IIIX nested probe (pX-N). (e) 
HTLV-I/ II pol PCI't products (SK110 and SK11 'I primers). (D) PCR 
products in (e) arc hybridized with HTLV-I (>01 nested probe (SK112). (E) 
PCR products in (e) arc hybridized with HTLV -II pol nested probe 
(SKJ 88). (F) {3-actin gene PCR products. Molecular sizes in base pairs (hp) 
arc indicated on the r(~iJI side. 
they were negative (similar to the ce ll lines in Fig 1E) with the 
exception of sa mples fr'om Olle patie nt w ith advanced CTCL (Fig 
2e,D). To further charactel'ize this patie llt, we used primers and 
nested probes for both H TLV-I and HTLV-II tnx region and 
detected the presence ofHTLV-1I tax sequences but not HTLV-I 
tax sequences (Fig 2A,B) . 
HTL V -II Amplification Products Contain Endogenous Ret-
roviral Sequences To confirm the identity of the HTLV-n 
PCR products de tected by PCR/So uthern blotting, we subcloned 
them and performed sequence analysis. In terestingly, o nly one third 
of the pol clones hybridized with the HTLV -U pol probe (data not 
shown) . Sequence analysis demonstrated that, whereas som e clones 
contained DNA seqllences with perfect homology to the HTLV-ll 
pol gene, the llJajority were produc ts of a human cndogenous 
sequence homologous to the HTL V pol gene (Fujihara et ai, 1994) 
(Fig 3). It appears that the presence of human endogenou 
retroviruses is responsibl e for the nonspecifIC amplifI cation prod-
ucts that were generated in our HTLV pol PCR. reactions (Fig 1q. 
In contrast. aU th e tnx clones hybridized to the HTLV-I1 taX' probe. 
DNA sequence analysis of the clo nes sh owed that they are 100% 
homologous to the HTLV-I1 tax gene (data not shown). Despit 
the filCt that we were able to detect HTL V - /I iax and pol sequence 
by PCR, we were unable to document HTL V -II proviral il1tegra-
tion in the genome of maEgnant T cells in th e peripheral blood (Fig 
2E). 
DISCUSSION 
Since the first molecular report suggesting that a HTLV -l-lik 
retrovirus is associated with CTCL (Manzari el nl, 1987), an 
increasin g number of reports have been published reporting a 
variable percentage of detcction rates of HTLV-I in patients wi th 
CTCL. Despite the fact that no definitive model of HTL V-I 
infection in CTCL has been advanced o r con firmed, some rep om 
have already proposed the use of anti-viral therapies for CTa 
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Figure 2. PCRlSouthern blot detection of HTLV-II sequences in 
one patient. MT2 ce ll line (positive control for I-ITLV-I) . MoT cell line 
(positive control for HTLV-II), alld biopsies of lymph node (LN). bone 
marrow (BM), erythrodermjc skin (SKN), cutaneous plaque (PLQ) , and 
peripheral blood lymphocytes (PBL) were analyzed. HTLV-I/ll lax peR 
products (SK43 and SK44 primers) were hyhridized with (A) HTLV-I (ax 
nested probe (pX-N) and (B) HTLV-Il (ax nested probe (SK45). HTLV-I/I1 
pol peR products (SKll 0 and SKlll) were hyhl-idized with (C) HTLV-I pol 
nested prohe (SKl12) and (D) HTLV-II pol nested probe (SK188) . (E) 
Southern blot analysis of EClJRl digested genomic DNA from MoT cell line 
and patient PBL hybrid ized with a full length HTLV-II prohe. Molecular 
sizes in hase pairs (hp) or kjlohases (kb) are indicated on the right side of each 
blo t. 
(Zucker-Franklin ef ai, 1991) and the use of molecular detection of 
HTLV-I as a diagnostic aid (Khan el ai, 1996). With the goal of 
determining when during disease progression and in what sites 
could HTL V -I proviral sequences be detected, we sought to 
develop a model that would be consistent with the natural history 
and epidemiology of CTCL. 
The hallmark of ATL is its occurrence rate in areas in which 
HTLV-I infection is endemic (Hollsberg and Hafler, 1993). The 
malignant T cells are predominantly CD4 + and strongly CD2 5 + 
(Waldman el ai, 1984); in up to 70% of cases there is cutaneo us 
involvement that can clinically mimic CTCL (Takatsuki el ai, 
1985) . Detection of serum antibodies to HTLV-l sur[,1ce proteins 
and the presence ofHTLV-I proviral DNA in the malign ant T-cell 
clone are the sille 'lila 11011 of ATL (Takatsuki el ai, 1985; HolJsberg 
and Hatler, 1993). In cont.rast, CTCL is a re latively indolent 
diso rder, and the malignant cells of this disease are CD4+ and 
weakly CD25+ (Waldman el ai, 1984). In addition, CTCL occurs 
sporadically and does not dem o nstrate case clustering o r e nde mic 
areas (Weinstock and Horm, 1988). T his is in direc t contrast with 
the clear epidemiology of ATL. 
Despite establi shing cell cultures comparabJ e to previou s studi es 
from which HTL V -I detection had been "e ported (M3nzari cf al. 
1987; Hall el ai, 1991; Zucker-Franklin c/ ai, 1991) , we were unabl e 
[Q detect HTLV-T proviral DNA sequen ces. To address the p ossi-
bili ti es that viral de tection in CTCL lllay be a function of viral load 
varying tlll'oughout disease progression o r early clearance of virus 
from the ski n, we evaluated skin and extracutaneous tissues £i'om all 
stages of CTCL: from "prec ursor states" of parapsoriasis to ad-
van ced cases with large cell transformation (Salhany cf al. 1988) and 
even one patient with concurrent CTCL and H o dgkin 's disease. In 
no instances did w e detec t HTL V -I retrovirus. O ur findings 
corroborate and ex te nd the studies that found no HTLV-l proviral 
sequences in skin (Lisby el ai, 1992; Bazarbachi cl ai, 1993; Doni el 
til, 1996), blood (Capesius el Ill. 1991; Bazarbachi el ai, .1993), and 
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1 " . 50 
PBL - 1 CCCTACAATCCAACCAGCTCAGGCCTGGTCGAGAGAACCAATGGTGTAAT 
II 11111 II 1111111111111111111 1 11111111111 1 111111 
HTLV-I I CCATACAACCCCACCAGCTCAGGCCTGGTCGAGAGAACCAATGGTGTAAT 
51 '" 100 
PBL- 1 CAAAAACTTACTAAATAAATATCTACTAGACTGTCCTAACCTTCCCCTAG 
1 111 111111111 1 11 1 1111111111111111111111111111111 11 
HTLV-II CAAAAACTTACTAAATAAATATCTACTAGACTGTCCTAACCTTCCCCTAG 
101 . .. 150 
PBL- 1 ACAATGCCATTCACAAAGCCCTTTGGACTCTCAATCAGCTAAATGTCATG 
111 1 11 11111111111111 11 111 11111111111111111 11 111111 
HTLV- II ACAATGCCATTCACAAAGCCCTTTGGACTCTCAATCAGCTAAATGTCATG 
151 . . 186 
PBL-1 AACCCCAGTGGTAAAACCCGATGGCAGCTTCACCAC 
II II I I I I I I I I I I I I I I 1 I I I I I I 1 I I I I I I I 
HTLV-II AACCCCAGTGGTAAAACCCGATGGCAAATCCACCAC 
. . . 50 
PBL- 2 CCCTACbATCCAACCAGCTCAGTGCCATGCAAGGGATCTGGAACTTAGGA 
1111111111111111111111111111 
HUMHTLRV TGCCATGCAAGGGATCTGGAACTTAGGA 
51 '" 100 
PBL- 2 AGTATTCATTATTGAGGGAAGGAGGAGGGAGGAAGCGAAGGAGGTCAGTG 
11/1111111111111 1 11 1 11111 1111 1 111 1 1111111111 11 1111 
HUMHTLRV AGTATTCATTATTGAGGGAAGGAGGAGGGAGGAAGCGAAGGAGGTCAGTG 
1 01 ' " 150 
PBL- 2 AATACGGTTCTGGCAATAAG TGTCAAGAAACTAATTGGGAGAACTGGTTT 
1 111 11111111111 1 111111111111111111111111111111 11 11 
HUMHTLRV AATACGGTTCTGGCAATAAGTGTCAAGAAACTAATTGGGAGAACTGGTTT 
151 .. .193 
PBL-2 AGGGTTGGAATAGCTTGTTbAAACCCGATGGCAGCTTCACCAC 
I II I I I I I I I I I 1 I I I I I I 
HUMHTLRV AGGGTTGGAATAGCTTGTT 
Figure 3. Sequence analysis of HTLV-II pol PCR amplification 
products from patient in Fig 2 demonstrates endogenous retroviral 
DNA sequences. Top. One third of the HTLV-II pol gene pe R amplifi-
cation products (PBL-I) exhibi t 100% sequence homology with HTLV-I1 
pol gene (HTLV-ll) (Genbank accession nO . L06854) except the primer 
regions (IIIIder/il/cd). BOUOIII, Two thirds of the HTLV-II pol gene peR 
amplification products (I>BL-2) show perfect sequence homology to a 
human endogenous HTLV -I pseudo-po' gene (HUMHTLR V) (Fuj ihara el 
ai, 1994; Gcnhank accession no. L1 9438) (primer regions arc IIlIderlill cd). 
CTCL-associated Iymphoproliferative diseases (Wood el ai , 1996a, 
1996b) . 
The validity of a model of a casual link of a retrovirus or 
pathogen with a human disease has a lways come from independent 
confirmatory reports subsequent to an initial observation (Winkel-
ma.n. 1993). The failure to d e tect fax gene proviral seq uences, the 
most conserved HTLV-I region (Hall el ai, 1991; Korber el ai, 
1991), in our study and the increasing number of other reports 
(Capesius el ai, 1991; Lisby et ai, 1992; Baza rbachi e( Ill, 1993; Boru 
ef ai, 1996) indicate that tlus has not been the case with retroviral 
infection and CTCL. In oth er studies re porting detection of 
HTL V -I proviral seque nces in CTCL, truncated pro viruses and low 
copy number (Hall et ai, 1991; Z ucker-Franklin ef ai, 1991) have 
been advanced as [,1ctors influ encing detection rates a.nd the lack of 
antibody response in CTCL (Lange-Wantzin el ai, 1986; Srivastava 
el ai, 1992). If such mechanisms are associated with HTL V-I 
infection in CTCL, an entire ly n ew and yet to be confi rm ed 
HTLV-I pathoge nesis must be ope rative in CTCL, because it is 
n either endem.ic for areas of HTLV-1 infection nor does CTCL 
have the clinicopathologic features of endemic HTLV-I ATL in the 
majority of cases. 
In samples from on e patie nt with advan ced CTCL with evidence 
of Itistologic large cdl transformation , HTL V -II pal and In.,,.. gene 
seq uences were detected. W e f.1iled to detect, however, the 
HTL V -II proviral genomic integration in peripheral blood lympho-
cytes of this patie nt by genomic Southern blot anal ys is. HTLV-II 
has been iso la ted /i'om patients with h airy-cell leukemi a and 
chronic neurodegenerative disease (Kalyanaram3n el ai, 1982; 
Hjelle el al. 1992; Ja cobson el ai, 1993); however , its association 
with these or other diseases ha s no t been de finitiv ely d efin ed. T he 
d e tec tion of HTLV-Il proviral seq uen ces in thi s patient and a 
mino rity of other CTCL patients (Zu cke r-Frank lin el al. 1992) can 
be correlated neither to HTL V -H infec tion nor to a signifi ca nt 
etiologic role in the maj ori ty of cases of CTCL. 
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The reported detection of HTLV-I/lI sequences in CTCL 
patients may represent an effect rather than a cause of the disease. 
In advanced CTCL, the degree of host immunosuppression is 
profound, mimicking that of acquired immunodeficiency syndrome 
(Heald e ( ai, 1994). Detection ofHTLV-lJ genes in this study and 
HTLV-I detection and expression in other reports may be an effect 
of CTCL-related immunosuppression. Other interpretations arc 
possible for the conflicting data reported in CTCL. Human endog-
enous retroviral-related sequences comprise up to 0.1 % of the 
human genome (Krieg e/ aI, 1992). Some of these have been 
isolated and proved to be related to HTL V (Mager and Freeman, 
1987). T he precise function of these genes, if any, has not been 
defined. The presence of these sequences was confirmed in this 
study. The previous positive results in other studies may be :1 result 
of the amplification of these endogenous genes. Last, not aIL studies 
have carefull y controlled for contamination and carry-over; unfor-
tunately, thjs may be responsible for some of the positive results 
reported in the li terature. Wood et al have demonstrated "false 
positive" PCR detection of HTLV-I DNA sequences in CTCL 
samples resulting from trace contamination (Wood ct. aI , 1996a). 
W e are confident that in our study, contamination has been tightly 
controlled (rom the onset. 
Based on our results and the currently avai lable molecular and 
epidemiologic data, HTL V -1 /11 is not a primary etiologic agent in 
the pathogenesis of CTCL. The association of CTCL with a 
putative HTL V -like retrovirus, with a currently undefined molec-
ular pathogenesis and epidemiology, has not been excluded. The 
use of HTL V -fiJI-specific reagents, however, has a limited appli-
cation in the detection and isolation of a new or related retrovirus. 
Futu re approaches would benefit from more powerful molecular 
techniques capab le of detecting small differences between two 
DNA popUlations (Lisityn et aI, 1993; Chang c/ aI, 1994) and 
experimental designs emphasizing the biologic behavior and epi-
demiology of CTCL (Lessin e/ aI, 1994). 
T llis ",ork lVas S//I'J)(!I1ed by " Depart", ellt 4 I/eternlls Allairs Carl:cr De"dol'II/WI 
A lllard RA"I 710 (to S.R.L.) alld Nat jOlla/ illstitlltes of Hen/tl, Crn llts 1'32 
A R -0 7565 (to C.L.), ROJ CA-5884 ·t (ti> A.H.R.), alIIt R29 CA-550"l7 (to 
S.R.L.). 
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